NASDAQ:TNGX | Cash Flow Statement | Tango Therapeutics, Inc.

Complete source-backed cash-flow history.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$55.34M
2026-03-31-$45.51M-$44.36M-$2,000.00$9.64M$79.85M
2025-12-31-$38.75M-$29.72M$222,000.00-$135.72M$219.38M
2025-09-30$15.88M
2025-06-30-$38.85M
2025-03-31-$39.88M-$41.7M$51,000.00$30.6M$2,000.00
2024-12-31-$37.67M-$36.65M$124,000.00$52.06M$969,000.00
2024-09-30-$29.17M
2024-06-30-$25.55M
2024-03-31-$37.91M-$37.86M$195,000.00-$11.2M$42.98M
2023-12-31-$30.76M-$27.47M$226,000.00$33.85M$1.47M
2023-09-30-$22.26M
2023-06-30-$20.71M
2023-03-31-$28.01M-$34.91M$620,000.00$31.55M$73,000.00
2022-12-31-$29.06M-$28.27M$1.04M-$12.61M$527,000.00
2022-09-30-$29.05M
2022-06-30-$24.86M
2022-03-31-$25.21M-$29.67M$1.56M-$11.72M$257,000.00
2021-12-31-$22.05M-$16.9M$696,000.00-$45.21M-$120,000.00
2021-09-30-$19.59M
2021-06-30-$4.49M
2021-03-31-$12.11M-$13.61M$165,000.00$20.61M$30.41M
2020-12-31-$8.86M-$18.06M$456,000.00-$59.21M-$61,000.00
2020-09-30-$26.8M
2020-06-30-$8.39M
2020-03-31-$7.91M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$101.59M-$138.89M$1.05M-$40.87M$222.5M
2024-12-31-$130.3M-$131.5M$754,000.00$86.13M$47.66M
2023-12-31-$101.74M-$117.98M$1.53M$41.43M$82.41M
2022-12-31-$108.18M-$109.08M$7.69M$26.4M$1.62M
2021-12-31-$58.24M-$59.53M$1.84M-$183.43M$357.33M
2020-12-31-$51.97M$70.07M$1.11M-$145.47M$80.88M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.